Skip to content
Search

Latest Stories

'Important partner' India to play key role in UK-led virtual Global Vaccine Summit

INDIA is among over 50 countries and organisations confirmed to participate in the UK-led virtual Global Vaccine Summit to be hosted by British Prime Minister Boris Johnson on Thursday (4).

Indian Prime Minister Narendra Modi or a high-level Indian representative is expected to participate live or with a pre-recorded message along with at least 35 heads of state or governments at the event, which aims to raise at least $7.4 billion (£5.9bn) for the global vaccine alliance Gavi.


Gavi -- a UN-backed organisation which coordinates vaccinations across the world -- will set up resources to protect future generations with vaccines and reduce disease inequality.

Johnson called for a "new era of global health co-operation" ahead of the summit that will see the launch of a new fundraising drive to support potential Covid-19 vaccines.

"I hope this summit will be the moment when the world comes together to unite humanity in the fight against disease," the prime minister said in a statement.

He said he hoped it would "inaugurate a new era of global health co-operation, which I believe is now the most essential shared endeavour of our lifetimes".

Lord Tariq Ahmad, Minister for South Asia and the Commonwealth, noted that the "response we have had from India is very positive".

"India's participation in Gavi and in supporting the (coronavirus) vaccine cannot in any way be underestimated and we continue to work together.

"It is an established fact that 50 per cent of the world’s vaccine production is currently in India, which makes it an important partner in that area."

In 2014, from being a recipient country of Gavi, India became a donor country and has contributed around $12 million to date.

"It is a notable achievement for India that it has become a supporter, and that demonstrates the steps India has taken in recent years," Ahmad said.

"When we look at the scale of production which India has of vaccines, it will be an important partner in ensuring a large number of vaccines are readily available in an equitable fashion."

The virtual summit this week comes against the backdrop of the University of Oxford's fast-track trials for a potential vaccine to protect against coronavirus.

However, it has a wider remit as the UK hopes it would help raise the funds required for Gavi to vaccinate over 300 million children against infectious diseases in the world's poorest countries over the next five years.

In April, the UK had set up a Vaccines Taskforce to support the discovery of a coronavirus vaccine and prepare industry supply chains to manufacture it at scale once it is developed.

"We have been working through our Vaccines Taskforce on strengthening our relations, both at a government-to-government level but also through the private sector and we will be looking to further strengthen that in the coming weeks and months," said Ahmad, in reference to India-UK collaboration in the field.

The coronavirus pandemic has killed more than 380,000 people since it emerged in China last December.

The WHO, UN children's agency UNICEF and Gavi warned last month that vaccine services were disrupted in nearly 70 countries, affecting some 80 million children under the age of one.

Polio eradication drives were suspended in dozens of countries, while measles vaccination campaigns were also put on hold in 27 countries, UNICEF said.

Recent Gavi-supported modelling from the London School of Hygiene and Tropical Medicine estimated that for every coronavirus death prevented by halting vaccination campaigns in Africa, up to 140 people could die from vaccine-preventable diseases.

"More children in more countries are now protected against more diseases than at any point in history," said Seth Berkley, chief executive of Gavi.

"However, these historic advances in global health are now at risk of unravelling as Covid-19 causes unprecedented disruption to vaccine programmes worldwide.

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less